¼¼°èÀÇ »ý¸í°úÇÐ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå
Life Science Software
»óǰÄÚµå : 1545604
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2024³â 09¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 182 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,130,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,390,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

»ý¸í°úÇÐ ¼ÒÇÁÆ®¿þ¾î ¼¼°è ½ÃÀå, 2030³â±îÁö 150¾ï ´Þ·¯ ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î Àü¸Á

2023³â 101¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â »ý¸í°úÇÐ ¼ÒÇÁÆ®¿þ¾î ¼¼°è ½ÃÀåÀº 2023³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ 5.9% ¼ºÀåÇÏ¿© 2030³â¿¡´Â 150¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀΠŬ¶ó¿ìµå µµÀÔ ºÎ¹®Àº CAGR 6.4%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ µ¿¾È 96¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿ÂÇÁ·¹¹Ì½º ¹èÆ÷ ºÎ¹®Àº ºÐ¼® ±â°£ µ¿¾È 4.9%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀå ¾à 28¾ï ´Þ·¯, Áß±¹Àº ¿¬Æò±Õ 5.6%ÀÇ ¼ºÀå·ü·Î ¼ºÀå Àü¸Á

¹Ì±¹ »ý¸í°úÇÐ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå ±Ô¸ð´Â 2023³â 28¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 24¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2023-2030³â ºÐ¼® ±â°£ µ¿¾È 5.6%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ´Ù¸¥ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ª ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ µ¿¾È °¢°¢ 5.7%¿Í 4.5%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ 4.7%ÀÇ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼°è »ý¸í°úÇÐ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ ¿ä¾à

»ý¸í°úÇÐ ¼ÒÇÁÆ®¿þ¾î°¡ ¿¬±¸°³¹ß¿¡ ÇʼöÀûÀÎ ÀÌÀ¯´Â ¹«¾ùÀϱî?

»ý¸í°úÇÐ ¼ÒÇÁÆ®¿þ¾î´Â Çö´ë °úÇÐ ¿¬±¸¿¡¼­ »ý¼ºµÇ´Â ¹æ´ëÇÑ ¾çÀÇ µ¥ÀÌÅ͸¦ °ü¸®, ºÐ¼® ¹× ÇØ¼®ÇÏ´Â µ¥ ÇÊ¿äÇÑ µµ±¸¿Í Ç÷§ÆûÀ» Á¦°øÇϱ⠶§¹®¿¡ ¿¬±¸ °³¹ß(R&D)¿¡ ÇʼöÀûÀÎ ¿ä¼Ò·Î ÀÚ¸® Àâ°í ÀÖ½À´Ï´Ù. µ¥ÀÌÅÍ °ü¸® ½Ã½ºÅÛ, »ý¹°Á¤º¸ÇÐ µµ±¸, ½ÇÇè½Ç Á¤º¸ °ü¸® ½Ã½ºÅÛ(LIMS) µîÀ» Æ÷ÇÔÇÑ ÀÌ·¯ÇÑ ¼ÒÇÁÆ®¿þ¾î ¼Ö·ç¼ÇÀº ¿¬±¸ÀÚµéÀÌ º¹ÀâÇÑ µ¥ÀÌÅÍ ¼¼Æ®¸¦ Á¤¸®ÇÏ°í ºÐ¼®Çϸç, ¿öÅ©Ç÷ο츦 °£¼ÒÈ­Çϰí, ±ÔÁ¦ ¿ä°ÇÀ» ÁؼöÇÒ ¼ö ÀÖµµ·Ï Áö¿øÇÕ´Ï´Ù. »ý¸í°úÇÐ »ê¾÷¿¡¼­ µ¥ÀÌÅÍ ±â¹Ý ÀÇ»ç°áÁ¤¿¡ ´ëÇÑ ÀÇÁ¸µµ°¡ ³ô¾ÆÁü¿¡ µû¶ó ´ë±Ô¸ð µ¥ÀÌÅÍ ºÐ¼® ¹× ÅëÇÕÀ» Áö¿øÇÏ´Â °í±Þ ¼ÒÇÁÆ®¿þ¾î ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, »ý¸í°úÇÐ ¼ÒÇÁÆ®¿þ¾î´Â ¿¬±¸ °³¹ß Ȱµ¿¿¡ ÇʼöÀûÀÎ ¿ä¼Ò·Î ÀÚ¸® Àâ°í ÀÖ½À´Ï´Ù.

±â¼úÀÇ ¹ßÀüÀº »ý¸í°úÇÐ ¼ÒÇÁÆ®¿þ¾î¸¦ ¾î¶»°Ô Çâ»ó½Ã۰í Àִ°¡?

±â¼úÀÇ ¹ßÀüÀº »ý¸í°úÇÐ ¼ÒÇÁÆ®¿þ¾îÀÇ ±â´ÉÀ» Å©°Ô Çâ»ó½ÃÄÑ ´õ¿í °­·ÂÇÏ°í »ç¿ëÀÚ Ä£È­ÀûÀÎ ¼Ö·ç¼ÇÀ» °³¹ßÇÒ ¼ö ÀÖµµ·Ï µ½°í ÀÖ½À´Ï´Ù. ÀΰøÁö´É(AI)°ú ¸Ó½Å·¯´× ¾Ë°í¸®ÁòÀ» ¼ÒÇÁÆ®¿þ¾î Ç÷§Æû¿¡ ÅëÇÕÇÔÀ¸·Î½á º¸´Ù Á¤±³ÇÑ µ¥ÀÌÅÍ ºÐ¼®ÀÌ °¡´ÉÇØÁ³°í, ¿¬±¸ÀÚµéÀº ÀÌÀü¿¡´Â ¹ß°ßÇϱ⠾î·Á¿ü´ø ÆÐÅϰú ÀλçÀÌÆ®¸¦ ¹ß°ßÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. Ŭ¶ó¿ìµå ÄÄÇ»ÆÃµµ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç, ´ë±Ô¸ð µ¥ÀÌÅÍ ¼¼Æ®¸¦ ÀúÀåÇϰí ó¸®ÇÒ ¼ö ÀÖ´Â È®Àå °¡´ÉÇÏ°í ¾ÈÀüÇÑ È¯°æÀ» Á¦°øÇϰí, Áö¸®ÀûÀ¸·Î ºÐ»êµÈ ÆÀ °£ÀÇ ½Ç½Ã°£ Çù¾÷À» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ¶ÇÇÑ, µ¥ÀÌÅÍ ½Ã°¢È­ µµ±¸ÀÇ ¹ßÀüÀº ¿¬±¸ÀÚµéÀÌ º¹ÀâÇÑ µ¥ÀÌÅ͸¦ ÇØ¼®ÇÏ°í ¿¬±¸ °á°ú¸¦ ½±°Ô Àü´ÞÇÒ ¼ö ÀÖµµ·Ï µ½°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀº »ý¸í°úÇÐ »ê¾÷ Àü¹Ý¿¡ °ÉÃÄ Ã·´Ü ¼ÒÇÁÆ®¿þ¾î ¼Ö·ç¼ÇÀÇ Ã¤ÅÃÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

»ý¸í°úÇÐ ¼ÒÇÁÆ®¿þ¾îÀÇ Ã¤ÅÃÀ» ÃËÁøÇÏ´Â Æ®·»µå´Â ¹«¾ùÀϱî?

»ý¸í°úÇÐ ¼ÒÇÁÆ®¿þ¾îÀÇ Ã¤ÅÃÀ» ÃËÁøÇÏ´Â ¸î °¡Áö ÁÖ¿ä Æ®·»µå´Â °³ÀÎ ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ °ü½É Áõ°¡, ºòµ¥ÀÌÅÍ ¹× µ¥ÀÌÅÍ ºÐ¼®ÀÇ ºÎ»ó, ±ÔÁ¦ Áؼö ¹× µ¥ÀÌÅÍ ¹«°á¼º¿¡ ´ëÇÑ Á߿伺 µî ¿©·¯ °¡Áö¸¦ ²ÅÀ» ¼ö ÀÖ½À´Ï´Ù. °³Àκ° À¯ÀüÀÚ ¹× ºÐÀÚ ÇÁ·ÎÆÄÀÏ ºÐ¼®ÀÌ ÇÊ¿äÇÑ ¸ÂÃãÀÇ·á´Â ´ë±Ô¸ð À¯Àüü ¹× ÀÓ»ó µ¥ÀÌÅ͸¦ °ü¸®ÇÏ°í ºÐ¼®ÇÒ ¼ö ÀÖ´Â ¼ÒÇÁÆ®¿þ¾î¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ºòµ¥ÀÌÅÍ¿Í µ¥ÀÌÅÍ ºÐ¼® Æ®·»µå´Â ÃֽŠ¿¬±¸¿¡¼­ »ý¼ºµÇ´Â ¹æ´ëÇÑ ¾çÀÇ µ¥ÀÌÅ͸¦ ó¸®Çϰí ÇØ¼®ÇÒ ¼ö ÀÖ´Â °í±Þ ¼ÒÇÁÆ®¿þ¾î ¼Ö·ç¼ÇÀÇ Çʿ伺À» Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ±ÔÁ¦ Áؼö¿Í µ¥ÀÌÅÍ ¹«°á¼º¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ Á¤È®ÇÑ ±â·Ï °ü¸®¿Í ÃßÀû¼ºÀ» º¸ÀåÇÒ ¼ö ÀÖ´Â ¼ÒÇÁÆ®¿þ¾î ¼Ö·ç¼ÇÀÇ µµÀÔÀÌ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â »ý¸í°úÇÐ ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀÇ ¿ªµ¿ÀûÀÎ ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

»ý¸í°úÇÐ ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÏ´Â ¿äÀÎÀº ¹«¾ùÀϱî?

»ý¸í°úÇÐ ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀÇ ¼ºÀåÀº ¿¬±¸ °³¹ß¿¡¼­ µ¥ÀÌÅÍ ±â¹Ý ÀÇ»ç°áÁ¤¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, °³ÀÎ ¸ÂÃãÇü ÀÇ·áÀÇ ºÎ»ó, ±ÔÁ¦ ¿ä°Ç Áؼö Çʿ伺 µî ¿©·¯ °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. À¯ÀüüÇÐ, ´Ü¹éÁúüÇÐ ¹× ±âŸ µ¥ÀÌÅÍ Áý¾àÀûÀÎ ºÐ¾ßÀÇ È®´ë·Î ÀÎÇØ ´ë±Ô¸ð µ¥ÀÌÅÍ ¼¼Æ®¸¦ °ü¸®ÇÏ°í ºÐ¼®ÇÒ ¼ö ÀÖ´Â ¼ÒÇÁÆ®¿þ¾î ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, »ý¸í°úÇÐ »ê¾÷ÀÌ µðÁöÅÐ ÀüȯÀ¸·Î ÀüȯÇϸ鼭 ¿öÅ©Ç÷ο츦 °£¼ÒÈ­Çϰí È¿À²¼ºÀ» Çâ»ó½ÃŰ´Â ¼ÒÇÁÆ®¿þ¾î ¼Ö·ç¼ÇÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, R&D Ȱµ¿ÀÌ ¾ö°ÝÇÑ ±âÁØ¿¡ ºÎÇÕÇÏ´ÂÁö È®ÀÎÇϱâ À§ÇØ µ¥ÀÌÅÍ ¹«°á¼º ¹× ±ÔÁ¦ Áؼö¿¡ ´ëÇÑ Á߿伺ÀÌ °­Á¶µÇ¸é¼­ ½ÃÀå ¼ºÀå¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. »ý¸í°úÇÐ »ê¾÷ÀÌ Áö¼ÓÀûÀ¸·Î ¹ßÀüÇÔ¿¡ µû¶ó ÷´Ü ¼ÒÇÁÆ®¿þ¾î ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä´Â ½ÃÀåÀÇ Áö¼ÓÀûÀÎ ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Á¶»ç ´ë»ó ±â¾÷ ¿¹½Ã(ÁÖ¸ñ¹Þ´Â 14°³ ±â¾÷)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Life Science Software Market to Reach US$15.0 Billion by 2030

The global market for Life Science Software estimated at US$10.1 Billion in the year 2023, is expected to reach US$15.0 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2023-2030. Cloud Deployment, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$9.6 Billion by the end of the analysis period. Growth in the On-Premise Deployment segment is estimated at 4.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.8 Billion While China is Forecast to Grow at 5.6% CAGR

The Life Science Software market in the U.S. is estimated at US$2.8 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.4 Billion by the year 2030 trailing a CAGR of 5.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.7% and 4.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.7% CAGR.

Global Life Science Software Market - Key Trends & Drivers Summarized

Why Is Life Science Software Becoming Essential in Research and Development?

Life science software is becoming essential in research and development (R&D) as it provides the tools and platforms necessary for managing, analyzing, and interpreting the vast amounts of data generated by modern scientific research. These software solutions, which include data management systems, bioinformatics tools, and laboratory information management systems (LIMS), enable researchers to organize and analyze complex datasets, streamline workflows, and ensure compliance with regulatory requirements. As the life sciences industry increasingly relies on data-driven decision-making, the demand for sophisticated software solutions that can handle large-scale data analysis and integration is growing, making life science software a critical component of R&D activities.

How Are Technological Advancements Enhancing Life Science Software?

Technological advancements are significantly enhancing the capabilities of life science software, leading to the development of more powerful and user-friendly solutions. The integration of artificial intelligence (AI) and machine learning algorithms into software platforms is enabling more advanced data analysis, allowing researchers to uncover patterns and insights that were previously difficult to detect. Cloud computing is also playing a key role, providing scalable and secure environments for storing and processing large datasets, and enabling real-time collaboration across geographically dispersed teams. Additionally, advancements in data visualization tools are making it easier for researchers to interpret complex data and communicate their findings. These technological innovations are driving the adoption of advanced software solutions across the life sciences industry.

What Trends Are Driving the Adoption of Life Science Software?

Several key trends are driving the adoption of life science software, including the increasing focus on personalized medicine, the rise of big data and data analytics, and the growing emphasis on regulatory compliance and data integrity. Personalized medicine, which requires the analysis of individual genetic and molecular profiles, is driving the demand for software that can manage and analyze large-scale genomic and clinical data. The trend towards big data and data analytics is also increasing the need for sophisticated software solutions that can process and interpret vast amounts of data generated by modern research. Additionally, the growing emphasis on regulatory compliance and data integrity is encouraging the adoption of software solutions that can ensure accurate record-keeping and traceability. These trends are contributing to the dynamic growth of the life science software market.

What Factors Are Driving the Growth of the Life Science Software Market?

The growth in the life science software market is driven by several factors, including the increasing demand for data-driven decision-making in research and development, the rise of personalized medicine, and the need for compliance with regulatory requirements. The expansion of genomics, proteomics, and other data-intensive fields is creating a demand for software solutions that can manage and analyze large datasets. Additionally, the shift towards digital transformation in the life sciences industry is driving the adoption of software solutions that can streamline workflows and improve efficiency. The growing emphasis on data integrity and regulatory compliance is also fueling market growth, as organizations seek to ensure that their research and development activities meet strict standards. As the life sciences industry continues to evolve, the demand for advanced software solutions is expected to drive sustained growth in the market.

Select Competitors (Total 14 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â